Literature DB >> 22589191

Early changes in the liver-soluble proteome from mice fed a nonalcoholic steatohepatitis inducing diet.

Anja Thomas1, Axel P Stevens, Matthias S Klein, Claus Hellerbrand, Katja Dettmer, Wolfram Gronwald, Peter J Oefner, Jörg Reinders.   

Abstract

Despite the increasing incidence of nonalcoholic steatohepatitis (NASH) with the rise in lifestyle-related diseases such as the metabolic syndrome, little is known about the changes in the liver proteome that precede the onset of inflammation and fibrosis. Here, we investigated early changes in the liver-soluble proteome of female C57BL/6N mice fed an NASH-inducing diet by 2D-DIGE and nano-HPLC-MS/MS. In parallel, histology and measurements of hepatic content of triglycerides, cholesterol and intermediates of the methionine cycle were performed. Hepatic steatosis manifested itself after 2 days of feeding, albeit significant changes in the liver-soluble proteome were not evident before day 10 in the absence of inflammatory or fibrotic signs. Proteomic alterations affected mainly energy and amino acid metabolism, detoxification processes, urea cycle, and the one-carbon/S-adenosylmethionine pathways. Additionally, intermediates of relevant affected pathways were quantified from liver tissue, confirming the findings from the proteomic analysis.
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22589191     DOI: 10.1002/pmic.201100628

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  10 in total

Review 1.  Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy.

Authors:  Diren Beyoğlu; Jeffrey R Idle
Journal:  Metabolites       Date:  2020-01-28

2.  Effect of chronic psychosocial stress on nonalcoholic steatohepatitis in mice.

Authors:  Barbara Czech; Inga D Neumann; Martina Müller; Stefan O Reber; Claus Hellerbrand
Journal:  Int J Clin Exp Pathol       Date:  2013-07-15

Review 3.  Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research.

Authors:  Joost Willebrords; Isabel Veloso Alves Pereira; Michaël Maes; Sara Crespo Yanguas; Isabelle Colle; Bert Van Den Bossche; Tereza Cristina Da Silva; Cláudia Pinto Marques Souza de Oliveira; Wellington Andraus; Venâncio Avancini Alves; Bruno Cogliati; Mathieu Vinken
Journal:  Prog Lipid Res       Date:  2015-06-11       Impact factor: 16.195

4.  Interaction of cCMP with the cGK, cAK and MAPK Kinases in Murine Tissues.

Authors:  Stefanie Wolfertstetter; Jörg Reinders; Frank Schwede; Peter Ruth; Elisabeth Schinner; Jens Schlossmann
Journal:  PLoS One       Date:  2015-05-15       Impact factor: 3.240

5.  Mitochondrial-related proteomic changes during obesity and fasting in mice are greater in the liver than skeletal muscles.

Authors:  Monika Nesteruk; Ewa E Hennig; Michal Mikula; Jakub Karczmarski; Artur Dzwonek; Krzysztof Goryca; Tymon Rubel; Agnieszka Paziewska; Marek Woszczynski; Joanna Ledwon; Michalina Dabrowska; Michal Dadlez; Jerzy Ostrowski
Journal:  Funct Integr Genomics       Date:  2013-11-01       Impact factor: 3.410

6.  Liver proteomic response to hypertriglyceridemia in human-apolipoprotein C-III transgenic mice at cellular and mitochondrial compartment levels.

Authors:  Grégory Ehx; Stéphanie Gérin; Grégory Mathy; Fabrice Franck; Helena Cf Oliveira; Anibal E Vercesi; Francis E Sluse
Journal:  Lipids Health Dis       Date:  2014-07-21       Impact factor: 3.876

7.  Metabolomic characteristics of cholesterol-induced non-obese nonalcoholic fatty liver disease in mice.

Authors:  Lan N Tu; Megan R Showalter; Tomas Cajka; Sili Fan; Viju V Pillai; Oliver Fiehn; Vimal Selvaraj
Journal:  Sci Rep       Date:  2017-07-21       Impact factor: 4.379

8.  Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease.

Authors:  Shu Dong; Zong-Ying Zhan; Hong-Yan Cao; Chao Wu; Yan-Qin Bian; Jian-Yuan Li; Gen-Hong Cheng; Ping Liu; Ming-Yu Sun
Journal:  World J Gastroenterol       Date:  2017-04-21       Impact factor: 5.742

Review 9.  Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes.

Authors:  Serena Scapaticci; Ebe D'Adamo; Angelika Mohn; Francesco Chiarelli; Cosimo Giannini
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-06       Impact factor: 5.555

10.  Reduced mitochondrial mass and function add to age-related susceptibility toward diet-induced fatty liver in C57BL/6J mice.

Authors:  Kerstin Lohr; Fiona Pachl; Amin Moghaddas Gholami; Kerstin E Geillinger; Hannelore Daniel; Bernhard Kuster; Martin Klingenspor
Journal:  Physiol Rep       Date:  2016-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.